Prof. Dr. Kürşat OKUYUCU

1. Impact of perinodal infiltration on recurrence in papillary thyroid cancer Impacto de la infiltración periganglionar en la recurrencia del carcinoma papilar de tiroides

Cinar A., Turan U., OKUYUCU K., Aydinbelge Dizdar N., Erol A., Bedi Alpay B., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.45, sa.1, 2026 (SCI-Expanded, Scopus)

2. Clinical course and features of thyroid oncocytic (Hurthle cell) cancer: Comparison with thyroid follicular cancer Curso clínico y características del cáncer oncocítico de tiroides (células de Hürthle): comparación con el carcinoma folicular de tiroides

OKUYUCU K., Turan U., Akkus Gunduz P., Ozkara M., Aydinbelge Dizdar N., Cinar A., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.44, sa.6, 2025 (SCI-Expanded, Scopus)

3. EVALUATION AND MANAGEMENT OF PARATHYROID INCIDENTALOMAS DETECTED BY ROUTINE NECK ULTRASONOGRAPHY WITH A MULTIDISCIPLINARY CLINICAL APPROACH

İNCE S., BULDANLI M. Z., ÇINAR A. S., HANÇERLİOĞULLARI O., OKUYUCU K.

Acta Endocrinologica , cilt.20, sa.2, ss.179-185, 2024 (SCI-Expanded, Scopus)

4. Clinical behaviour of papillary thyroid cancer oncocytic variant: Stage-matched comparison versus classical and tall cell variant papillary thyroid cancer Comportamiento clínico de la variante oncocítica del cáncer papilar de tiroides: comparación de su evolución frente al cáncer papilar, variantes clásica y de células altas

OKUYUCU K., İNCE S., ÇINAR A. S., San H., Samsum M., Dizdar N., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.42, sa.2, ss.100-105, 2023 (SCI-Expanded, Scopus)

5. Yttrium-90 (Y-90) resin microsphere therapy for patients with unresectable hepatocellular carcinoma. Identification of successful treatment response predictors and patient selection

ARSLAN N., İNCE S., OKUYUCU K., ŞAN H., ALAGÖZ E., KARADURMUŞ N., et al.

Annali Italiani di Chirurgia , cilt.92, sa.6, ss.623-631, 2021 (SCI-Expanded, Scopus)

6. Prognostic parameters in recurrent colorectal cancer: A role of control or restaging by FDG-PET/CT Prognostički parametri u rekurentnom kolorektalnom karcinomu: uloga kontrole ili ponovnog određivanja stepena bolesti FDG-PET/CT-om

HANÇERLİOĞULLARI O., OKUYUCU K., İNCE S., Peker S., Arslan N.

Vojnosanitetski Pregled , cilt.77, sa.2, ss.201-208, 2020 (SCI-Expanded, Scopus)

7. Prognostic risk factors for rare oncocytic variant in 101 cases of papillary thyroid carcioma

ALAGÖZ E., OKUYUCU K., İNCE S., Mahmudov S., Ayan A., Demirci I., et al.

Hellenic Journal of Nuclear Medicine , cilt.22, sa.2, ss.116-122, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Evaluation of predictor variables of diagnostic [18F] FDG-PET/CT in fever of unknown origin

OKUYUCU K., ALAGÖZ E., Demirbas S., İNCE S., Karakas A., KARAÇALIOĞLU A. Ö., et al.

Quarterly Journal of Nuclear Medicine and Molecular Imaging , cilt.62, sa.3, ss.313-320, 2018 (SCI-Expanded, Scopus)

9. Complementary role of parathormone washout test to 99m Tc-MIBI parathyroid scintigraphy and histopathologic analysis of cell types in parathyroid adenomas Gammagrafía paratiroidea con 99m Tc-MIBI: valor complementario de la paratohormona en el aspirado y análisis histopatológico de los tipos de células en los adenomas paratiroideos

İNCE S., Emer O., Deveci S., OKUYUCU K., ALAGÖZ E., San H., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.37, sa.4, ss.205-210, 2018 (SCI-Expanded, Scopus)

10. Utility of FDGPET/CT in themanagement of primary testicular lymphoma Primer testis lenfomasında FDG PET/BT’nin yararlılığının değerlendirilmesi

OKUYUCU K., İNCE S., ALAGÖZ E., ATAŞ E., Arslan N.

Molecular Imaging and Radionuclide Therapy , cilt.27, sa.2, ss.61-65, 2018 (Scopus, TRDizin)

11. Utility of FDG-PET/CT in primary central nervous system lymphoma and its contribution to prognosis estimation

OKUYUCU K., ALAGÖZ E.

Gulhane Medical Journal , cilt.59, sa.2, ss.44-48, 2018 (Scopus, TRDizin)

12. Angiographic results of the patients with positive transient ischemic dilatation on their gated myocardial perfusion imaging scans

İNCE S., KARAÇALIOĞLU A. Ö., Şan H., Emer Ö., ALAGÖZ E., YILDIRIM E., et al.

Gulhane Medical Journal , cilt.60, sa.2, ss.37-41, 2018 (Scopus, TRDizin)

13. Can metabolic tumor parameters on primary staging 18F-FDG PET/CT aid in risk stratification of primary central nervous system lymphomas for patient management as a prognostic model? ¿Pueden contribuir los parámetros tumorales metabólicos, establecidos mediante 18F-FDG PET/TC para estadificación primaria, a la estratificación del riesgo de los linfomas del sistema nervioso central, para el tratamiento del paciente como modelo pronóstico?

OKUYUCU K., ALAGÖZ E., İNCE S., Ozaydin S., Arslan N.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.37, sa.1, ss.9-14, 2018 (SCI-Expanded, Scopus)

14. Clinical and prognostic significance of preoperative and postoperative neutrophil/lymphocyte ratio and platelet/ lymphocyte ratio in patients undergoing major abdominal surgery

HANÇERLİOĞULLARI O., KAYMAK Ş., OKUYUCU K., İNCE S., ŞENOCAK R., Urkan M., et al.

Gulhane Medical Journal , cilt.60, sa.4, ss.119-124, 2018 (Scopus, TRDizin)

15. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma

OKUYUCU K., ALAGÖZ E., İNCE S., Arslan N.

Endokrynologia Polska , cilt.68, sa.6, ss.623-630, 2017 (SCI-Expanded, Scopus)

16. Uptake patterns of untreated primary gastrointestinal extranodal lymphomas on initial staging 18F-FDG PET/CT and metabolic tumor parameters Primer ekstranodal gastrointestinal sistem lenfomalarında primer evreleme 18F-FDG PET/BT’de tutulum paternleri ve metabolik tümör parametreleri

ALAGÖZ E., OKUYUCU K., İNCE S., Kantarcıoğlu M., Özaydın Ş., Heper C., et al.

Molecular Imaging and Radionuclide Therapy , cilt.26, sa.3, ss.83-92, 2017 (Scopus, TRDizin)

17. Prognostic importance of metabolic tumor parameters on initial FDG-PET/CT in patients with isolated infradiaphragmatic Hodgkin’s lymphoma Prognostički značaj metaboličkih tumorskih parametara na inicijalnom FDG-PET/CT kod bolesnika sa izolovanim infradijafragmalnim Hočkinovim limfomom

ALAGÖZ E., OKUYUCU K., İNCE S., Ozgur G., ÖZTÜRK M., KARAÇALIOĞLU A. Ö., et al.

Vojnosanitetski Pregled , cilt.74, sa.8, ss.728-735, 2017 (SCI-Expanded, Scopus)

18. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients

GÜNALP B., OKUYUCU K., İNCE S., Ayan A., ALAGÖZ E.

Hellenic Journal of Nuclear Medicine , cilt.20, sa.2, ss.122-127, 2017 (SCI-Expanded, Scopus)

19. Clinical significance of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in the follow-up of colorectal cancer: Searching off approaches increasing specificity for detection of recurrence

İNCE S., OKUYUCU K., Hancerliogullarl O., ALAGÖZ E., San H., Arslan N.

Radiology and Oncology , cilt.51, sa.4, ss.378-385, 2017 (SCI-Expanded, Scopus)

20. Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma

OKUYUCU K., Ozaydln S., ALAGÖZ E., Ozgur G., İNCE S., Oysul F. G., et al.

Radiology and Oncology , cilt.50, sa.4, ss.360-369, 2016 (SCI-Expanded, Scopus)

21. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18F-FDG PET/CT

OKUYUCU K., İNCE S., ALAGÖZ E., Emer O., San H., Balkan E., et al.

Hellenic Journal of Nuclear Medicine , cilt.19, sa.3, ss.208-217, 2016 (SCI-Expanded, Scopus)

22. Complete remission on 18-fluorodeoxyglucose positron emission tomography/computed tomography after nivolumab treatment in a patient with indolent hodgkin lymphoma

ALAGÖZ E., İNCE S., OKUYUCU K., Ayan A., San H., KARADURMUŞ N.

Translational Cancer Research , cilt.5, sa.3, ss.320-323, 2016 (SCI-Expanded, Scopus)

23. Thyrotropinoma with Graves' disease detected by the fusion of indium-111 octreotide scintigraphy and pituitary magnetic resonance imaging

OKUYUCU K., ALAGÖZ E., Arslan N., Taslipinar A., Deveci M. S., Bolu E.

Indian Journal of Nuclear Medicine , cilt.31, sa.2, ss.141-143, 2016 (Scopus)

24. Primary sacral lymphoma initally supposed to be sacroiliitis on bone scintigrapy

OKUYUCU K., ALAGÖZ E., Özaydin Ş., Güzelkücük Ü., Arslan N.

Gulhane Medical Journal , cilt.58, sa.3, ss.327-328, 2016 (Scopus, TRDizin)

25. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: Comparison with classic variant of papillary thyroid carcinoma

OKUYUCU K., ALAGÖZ E., Arslan N., Emer O., İNCE S., Deveci S., et al.

Nuclear Medicine Communications , cilt.36, sa.10, ss.1021-1025, 2015 (SCI-Expanded, Scopus)

Prof. Dr. Kürşat OKUYUCU

Yayınlar & Eserler